Systems pharmacology of hepatic metabolism in zebrafish larvae. (2016)

• Record Type: Journal Article
• Authors: van Wijk, Rob C.; Krekels, Elke H.J.; Hankemeier, Thomas; Spaink, Herman P.; van der Graaf, Piet H.
• Is Part Of: Drug discovery today. Volume 22(2016)
• Page Start: 27
• Page End: 34
• Publication Date: 2016
• Subjects: Drug development -- Periodicals; Physiology, Pathological -- Periodicals; Drugs -- Testing -- Periodicals; Diseases -- Animal models -- Evaluation -- Periodicals; 616.027
• DOI: 10.1016/j.ddmod.2017.04.003
• Languages: English
• ISSNs: 1740-6757

Abstract

Abstract : Interspecies translation of pharmacological processes needs to improve to reduce attrition in drug development. Systems pharmacology integrates systems biology and pharmacometrics to characterise and quantify system-specific behaviour upon exposure to drugs in different species. The zebrafish is a suitable vertebrate model organism for systems pharmacology, combining high-throughput potential with high genetic homology to higher vertebrates. Zebrafish larvae have been increasingly used for drug screens, but the influence of internal drug and metabolite exposure is hardly studied. Quantifying this internal exposure is essential for establishing both exposure-response and dose-exposure relationships, needed for translation. The zebrafish may also serve as a suitable model species for translational studies on the occurrence of hepatotoxicity and the influence of hepatic dysfunction on drug metabolism.